Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2018 Volume 17 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2018 Volume 17 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome

  • Authors:
    • Yuanyuan Kang
    • Yan Sun
    • Ying Zhang
    • Zhe Wang
  • View Affiliations / Copyright

    Affiliations: Department of Emergency and Oral Medicine, The School of Stomatology, China Medical University and Liaoning Institute of Dental Research and Liaoning Province Key Laboratory of Oral Diseases and Liaoning Province Translational Medicine Research Center of Oral Diseases, Shenyang, Liaoning 110002, P.R. China, Department of Pathology, The Second Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110004, P.R. China
  • Pages: 1993-1997
    |
    Published online on: November 15, 2017
       https://doi.org/10.3892/mmr.2017.8083
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the expression and effect of cytochrome c (Cytc) in patients with primary Sjogren's syndrome (pSS). In total, 35 newly diagnosed pSS patients and 35 healthy subjects were enrolled in the present study. The mRNA expression levels of Cytc were detected using reverse transcription‑polymerase chain reaction and RT‑quantitative PCR. The expression of the Cytc protein in labial salivary glands was detected by immunohistochemistry and was associated with the integral optical density (IOD) of clinical and laboratory variables. In addition, the content of Cytc in the cytoplasm and mitochondria were examined. The mRNA and protein expression levels of Cytc, and the content of Cytc in the cytoplasm of the pSS patients was increased significantly compared with the healthy controls (P<0.05). The content of Cytc in the mitochondria was significantly decreased compared with the healthy controls (P<0.05). The IOD of Cytc protein levels was positively correlated with immunoglobin G (r=0.8142, P<0.05) and erythrocyte sedimentation rate (r=0.7512, P<0.05). Cytc was upregulated in the pSS patients, indicating the potential role of Cytc in the pathogenesis and development of pSS. Further studies may facilitate the development of targeting this molecular pathway for the treatment of pSS.

Introduction

With a prevalence of 0.2–1.4%, primary Sjogren's syndrome (pSS) is one of the most common chronic, slowly progressing systemic autoimmune diseases. Its main symptoms are kerato-conjunctivitis sicca and xerostomia. The extremely various clinical picture is characterized by multiple extraglandular manifestations (EGMs) and associated diseases. The women accounting for 90% of all cases in pSS. The onset age in 30–60 years. However, both distributions by age and by sex show geographical and ethnic differences (1–3).

The precise etiology remains unclear. Multiple factors, including viral infection, hormonal balance and genetic background were involved in the pathogenesis of pSS (4). The influence of abnormal apoptosis in this disease has attracted considerable attention (5–8). Cell apoptosis was a cell suicide under the control of gene in the development of individual activities. It was a programmed cell death process actively by the gene encoding with multicellular organism to regulate the body growth and maintain the stability of the internal environment. Cell apoptosis was involved in a variety of physiological situations, including immunity, embryogenesis and carcinogenesis. It was generally considered that cell apoptosis was implemented through two different pathway (exogenous and endogenous pathways). Exogenous pathway of apoptosis was regulated by the family of the Bcl-2 protein, promoting material such as the cytochrome c (Cytc), which induced apoptosis acts on the mitochondria. The endogenous pathway of apoptosis was occurred by Fas/FasL interactions (9). It is generally believed that the regulatory mechanisms for pSS are mainly through endogenous death receptor pathway. Kong et al (10), Treviño-Talavera et al (7) have already reported the expression of Fas/FasL in the salivary glands of patients with pSS, suggested that the endogenous death receptor pathway was involved in pSS. However, it is not clear that whether the exogenous plays an important role in the patients with pSS.

Cytc was a key factor of exogenous pathway. Once released into the cytosol, Cytc binds to apoptotic protease activating facter-1 (Apaf-1) and procaspase-9, apoptosome was formed, apoptosis was initiated (11). However, the changes in Cytc expression in pSS patients remain unclear. In the present study, the expression of Cytc in the labial salivary glands of pSS patients and healthy controls were examined to investigate the possible role of Cytc in the pathogenesis and development of pSS.

Materials and methods

Patients and group

The group comprised 35 patients (33 women and 2 men) with a mean age of 44.42±2.62 years. All patients were recruited from the Department of Emergency and Oral Medicine, School of Stomatology, China Medical University between September 2014 and September 2016 and diagnosed with pSS fulfilled the American-European Consensus Group Criteria for this diagnosis (12) and individuals with other rheumatic diseases, infections, or malignant tumors were excluded from the study. The control group included 35 cases (32 women and 3 men) with a mean age of 40.11±1.32 years. Healthy controls specimens mainly come from the lip trauma (the 30 cases come from lip trauma, the 5 cases come from the abnormal labial gland surrounding the cyst during the operation of mucous cyst). There were no significant differences in the ages or sex ratios between the two groups. Both the research protocol and the consent forms were approved by the Research Ethics Committee of School of Stomatology, China Medical University.

Experimental specimen collection

Each patient was cutted down 0.6×0.6 cm labial gland tissue of the lower lip under the local anesthesia. One part of fresh specimens was immersed in 4% formaldehyde fixed, conventional paraffin embedding. The other part was put into the liquid nitrogen immediately, preservation in −70°C condition.

Experimental methods
Reverse transcription-polymerase chain reaction (RT-PCR)

Total tissue RNA was extracted from tissue using the TRIzol kits (Sangon Biotech Corporation, Shanghai, China), according to the manufacturer's instructions. The quality and yield of the RNA samples were determined by ultraviolet spectrophotometer and the concentration was adjusted to 1 µg/µl for reverse transcription. The Cytc and GADPH was run in the same reaction. RT reaction system: RNA 2 µl, 10X RT buffer 2 µl, MgCL2 4 µl, dNTP 2 µl, RNase free H2O 7.5 µl, RNase inhibitor 0.5 µl, AMV 1 µl, random 9 primer 1 µl, reaction condition: 30°C for 10 min, 42°C for 30 min, 99°C for 5 min, 5°C for 5 min. PCR reaction system: cDNA 2 µl, forward primer 1 µl, reverse primer 1 µl, dNTP 0.5 µl, 5X RT buffer 5 µl, EsayTaq 0.125 µl. Reaction condition: 95°C 1 min, 95°C 15 sec, 60°C 15 sec, 72°C 45 sec for 40 cycles. RT-PCR products was separated on 2% agarose gels. After stained with ethidium bromide, gel images were photographed with Chemi Imager™ 4400. The gray value of positive electrophoresis strip were tested by professional digital analysis software. The expression of mRNA was normalized against the expression of the GAPDH gene.

The sequences of the primer pairs are: Cytc, 5′-GGGCGAGAGCTATGTAATGCAAG-3′ and 5′-TACAGCCAAAGCAGCAGCTCA-3′ (132 bp); GAPDH, 5′-ACCACAGTCCATGCCATCAC-3′ and 5′-TCCACCACCCTGTTGCTGTA-3′ (439 bp).

RT-qPCR

Total tissue RNA was extracted from tissue using the TRIzol kits (Sangon Biotech Corporation), according to the manufacturer's instructions. The quality and yield of the RNA samples were determined by ultraviolet spectrophotometer and the concentration was adjusted to 1 µg/µl for reverse transcription. The RNA was reverse-transcribed to form cDNA using a ReverTra Ace qPCR RT kit (Toyobo, Osaka, Japan). RT reaction system: RNA 1 µg, 5X PrimeScript RT Master Mix 4 µl, RNase Free dH2O was added to reach 20 µl, reaction condition: 37°C for 15 min, 85°C for 5 min. qPCR was performed using the Light Cycler TaqMan Master kit (Toyobo), according to the manufacturer's instructions, qPCR reaction system: SYBR Premix Ex Taq II 10 µl, cDNA1 µl, forward primer 0.5 µl, reverse primer 0.5 µl, Sterile water 8 µl. The cycling conditions were as follows: Initial denaturation at 95°C for 1 min, 30 cyles of denaturation at 94°C for 30 sec, annealing at 58°C for 30 sec and extension at 72°C at 10 sec, followed by 72°C for 2 min and 16°C for 5 min. The relative mRNA expression levels of Cytc were determined using the comparative Ct method, using arithmetic formulae from the MxPro software tool. The relative expression of Cytc was calculated using the ΔΔCt method. The expression of mRNA was normalized against the expression of the GAPDH gene.

Immunohistochemical staining for Cytc

The fixed biopsy specimen slides were fixed in Carnoy's fixative and embedded in paraffin wax. Paraffinized tissues were sectioned to 4 µm thickness, deparaffinized in xylene and rehydrated through a series of concentrations of ethanol. Antigen retrieval was carried out using an electric pressure cooker (110°C, 20 min) in 10 mM citrate buffer (pH 6.0). The sections were immersed in blocking solution (Dako Corp., Carpinteria, CA, USA) for 10 min at room temperature followed by washing with phosphate buffered saline (pH 7.4) plus 0.1% Tween-20 for blocking the endogenous peroxidase activity. The sections were incubated with rabbit anti-human Cytc (BD Pharmingen, Santiago, CA, USA) overnight at 4°C which were diluted 1:50. The slides were washed for 5 min, sections were then incubated with peroxidase-conjugated goat anti-rabbit secondary antibody for 1 h at room temperature; both of which were diluted 1:200. The reactions were developed using a DAB substrate kit, with hematoxylin as counterstain. Each slide was evaluated by one of the authors under a microscope (Nikon, Tokyo, Japan).

At higher magnification (×400), five visual field were selected randomly, the expression positive signal was analyzed by Image-proplus software. Compared the level of Cytc protein in pSS group and healthy control group of labial salivary gland according to the integral optical density (IOD) as a parameter for semi-quantitative detection.

Determination of the content of Cytc

The tissue homogenate was preparation and the mitochondria was extracted: Reference Zydowo et al methods (13). Labial gland tissue were weight after rinsed with cold saline, 10% tissue homogenate were made with precooling medium homogenate (0.1 mol/l Tris-HCl, 1 mol/l KCl, 0.25 mol/l sucrose, pH 7.4). At low temperature with 15 min, centrifugation of 600 g was conducted. Take the supernatant, centrifugation of 1,800 × g was conducted again. The cold slurry medium was added with the precipitation, the mitochondria suspension was made and saved −20°C.

Determination of Cytc: 1 ml Cytc standard (80 mg/ml) dilution was taken, add sodium sulfate when vibration, the density of sodium sulfatewas measured at 520 nm. The standard curve was draw with the concentration of the standard for horizontal ordinate, optical density for longitudinal coordinate. The concentration of sample were calculated by the standard curve.

Statistical analysis

Statistical analysis was performed using SPSS 17.0 software. The data are presented as the median ± interquartile. The Mann-Whitney rank-sum test were used to compare Cytc mRNA and Cytc protein between the pSS and the healthy controls. In addition, correlations between the levels of IOD of Cytc protein with clinical and laboratory variables were assessed using Spearman's rank correlation. P<0.05 was considered to indicate a statistically significant difference.

Results

RT-PCR and qRT-PCR

To determine the mRNA expression level of Cytc, the specimen from the pSS patients and the healthy controls were separated. The total mRNA was isolated and the mRNA expression level of Cytc was investigated with RT-PCR. Using SPSS 17.0 software, the data are presented as the fold-change in the gene expression normalized against GAPDH. As shown in Fig. 1A and B, there was a 3.45-fold increase in the relative mRNA expression of Cytc in the pSS patients prior to the control.

Figure 1.

Result of RT-PCR and qRT-PCR. (A) The levels of Cytc mRNA and GAPDH was expressed by electrophoresis bands. (B) Expression levels of Cytc mRNA were examined by RT-PCR and normalized against the expression of the GAPDH gene. (C) Expression levels of Cytc mRNA were examined by qRT-PCR and normalized against the expression of the GAPDH gene. *P<0.05 vs. healthy controls. Cytc, cytochrome c.

We also used qRT-PCR to explore the mRNA expression level of Cytc. In this experiment, we divided the control group into two groups according to the source of the sample. As shown in Fig. 1C, there was a 2.66-fold increase in the relative mRNA expression of Cytc in the pSS patients prior to the control from the lip trauma, there was a 2.96-fold increase in the relative mRNA expression of Cytc in the pSS patients prior to the control from the operation of mucous cyst, but there was no significant difference between the two control groups (Fig. 1C).

Immunohistochemistry staining

To evaluate the local effect of Cytc in pSS, we applied immunohistochemical staining to determine the expression of Cytc in the labial salivary glands from pSS. Freshly explanted lower lip biopsy specimens were sectioned and stained with anti-Cytc. All 35 pSS samples exhibited distinct expression of Cytc. Brown particles were mainly distributed in the cytoplasm of acinar epithelial cells, ductal epithelial cells and the infiltration of focal lymphocytic. In contrast, the labial salivary glands from the control exhibited lower expression of Cytc. It was mainly expressed in mesenchymal cells and glandular epithelial cells with a weak expression of Cytc. Overall, the expression of Cytc in pSS was stronger and more widely distributed than the control (Figs. 2 and 3A).

Figure 2.

(A) Photomicrograph showing the features of histopathological in pSS (magnification, ×200). (B) Photomicrograph showing the features of histopathological in healthy controls (magnification, ×200). The labial salivary glands of pSS patients exhibit increased Cytc expression. (C and E) Shown is the expression of the Cytc in the labial salivary glands of pSS (magnification, ×200; magnification, ×400) and (D and F) healthy controls (magnification, ×200; magnification, ×400), as determined by immunostaining using specific antibodies. *P<0.05 vs. healthy controls. Cytc, cytochrome c.

Figure 3.

The result of testing the (A) IOD and (B) content of Cytc between the pSS and the control. *P<0.05 vs. healthy controls. Cytc, cytochrome c.

The content of Cytc

There was great differences between the two groups (P<0.05). The cytoplasm content of Cytc in pSS was 6.07±1.84, while the control group was 1.25±1.45. The mitochondrial content of Cytc in pSS was 0.76±1.32, while the control group was 5.57±0.59 (Fig. 3B).

The correlation between the expression of Cytc protein and clinical and laboratory variables

To further determine the relationship between the IOD of Cytc protein levels and laboratory test results including the titers of SSA, SSB, ANA, ESR, CRP, RF and IgG levels. It was found that the IOD of Cytc protein levels was positively correlated with ESR (r=0.8142, P<0.05) (Fig. 4A) and IgG (r=0.7512, P<0.05) (Fig. 4B). However, no significant correlations were found between the IOD of Cytc protein levels and the other laboratory values (data not shown). Interestingly, when patients were grouped according to test results normal or abnormal, elevated the IOD of Cytc protein levels exhibited were found in the groups with high titers of ANA (7.88±0.22 vs. 1.22±0.12, P=0.0032) or high concentration of CRP (16.11±0.12 vs. 3.22±0.45, P=0.0054), RF (7.21±2.34 vs. 1.67±0.12, P=0.0035), as shown in Table I.

Figure 4.

Correlation of the IOD of Cytc protein levels with laboratory values. Positive correlation was observed between the IOD of Cytc protein levels and ESR (A), IgG (B). ESR, erythrocyte sedimentation rate; IgG, immunoglobulin G.

Table I.

Comparison of the IOD levels of Cytc protein between pSS patients with normal or abnormal laboratory values.

Table I.

Comparison of the IOD levels of Cytc protein between pSS patients with normal or abnormal laboratory values.

IOD levels of Cytc protein

ParameterNormal mean ± SD (n)Abnormal mean ± SD (n)P-value
A-SSA3.22±1.02 (5)5.17±4.03 (30)0.1142
A-SSB5.22±2.21 (18)3.53±0.12 (17)0.6433
ANA1.22±0.12 (5)7.88±0.22 (30)0.0032b
CRP3.22±0.45 (25)16.11±0.12 (10)0.0054b
RF1.67±0.12 (15)7.21±2.34 (20)0.0035b
IgM6.23±3.20 (18)10.08±2.14 (17)0.0335a
IgA2.16±2.11 (30)7.24±1.24 (5)0.0132a

{ label (or @symbol) needed for fn[@id='tfn1-mmr-17-01-1993'] } P<0.05 means significant difference

a (P<0.05)

b (P<0.01). Laboratory values such as A-SSA, A-SSB, ANA and RF positive were defined as abnormal, while laboratory parameters such as CRP, IgM and IgA above limit values were defined as abnormal A-SSA, anti-Ro/SSA antibody; A-SSB, anti-La/SSB antibody; ANA, antinuclear antibody; CRP, C-reactive protein; RF, rheumatoid factor; IgM, immunoglobulin M; IgA, immunoglobulin A.

Discussion

pSS is a type of autoimmune disease concerning exocrine glands of whole body, which is characterized by the infiltration of lymphocytes and plasma cell, mainly affecting lacrimal gland as well as salivary gland. Hyposecretion of gland and some symptoms can be caused, for instance, xerostomia, xerophthalmia. On the early stage of disease, the local exocrine gland was injured, with the aggravation of local inflammation, uncontrollable immune system will induce systemic disease and develop into malignancy eventually. At present, the etiology and pathogenic mechanisms are not very clear. In recent years, from a large number of literature, we can find that pSS may related to the endogenous pathway of apoptosis (7,10). Sisto M (14) found that ectodysplasin-A2 (EDA-A2) and its receptor X-linked ectodermal dysplasia receptor (XEDAR) are overexpressed in pSS salivary gland epithelial cells in comparison with healthy individuals and that the EDA-A2/XEDAR system in these cells is involved in the induction of apoptosis via caspases activation. Horai (15) observed that polyinosinic: Cytidylic acid induced apoptosis of primary salivary gland epithelial cells in vitro compared with a relatively low prevalence of apoptosis found in the ducts and alveoli of labial salivary glands in vivo. Katsiougiannis (16) discovered that endoplasmic reticulum stress is activated in minor salivary gland epithelial cells from pSS patients and controls. Endoplasmic reticulum stress-induced apoptosis in human salivary gland cells leads to cell surface and apoptotic blebs relocalization of Ro/SSA and La/SSB autoantigens.

Cytc is a mitochondrial protein responsible for transferring electrons between electron transport chain complexes III and IV. Under normal circumstances, Cytc was intergrated into the inner membrane of mitochondrial. When stimulated by the apoptosis, Bax forms oligomers and intergrated into the outer membrane of mitochondrial, inducing and changing permeability of mitochondrial membrane, promoting the release of Cytc. It also contribute to the formation of apoptosome (which consists of Apaf-1, Cytc and caspase-9), make effector caspases alive to induce apoptosis (17,18). The release of Cytc from the mitochondria has been considered as a commitment step in intrinsic apoptosis (19,20).

The present study demonstrated that the expression of Cytc mRNA turns enhanced in the labial gland of pSS-patients and it has statstical signaficance when compared with the group of health patients (P<0.05). But it notable that the Cytc in mitochondria is lower than control-group (P<0.05). Cytc was released from mitochondria to cytoplasm, not only reduce the respiratory function of mitochondria but also induce the key procedure of apoptosis, activating caspases reaction and apoptosis. In addition, our investigations have revealed a close correlation of Cytc levels with the disease activity and severity in pSS patients. Our data have clearly shown that the levels of Cytc protein positively correlate with ESR and IgG. We provide new evidence indicating involvement of Cytc overactivation in the disease pathophysiology.

In conclusion, the present study demonstrated that Cytc is upregulated in pSS patients, indicating a possible role of Cytc in the pathogenesis and development of pSS.

Acknowledgements

This study was supported by grants from the Youth Scientific Research Fund Project of the School of Stomatology, China Medical University (no. K101593-16-05).

References

1 

Olsson P, Turesson C, Mandl T, Jacobsson L and Theander E: Cigarette smoking and the risk of primary Sjögren's syndrome: A nested case control study. Arthritis Res Ther. 19:502017. View Article : Google Scholar :

2 

Xin Y, Cai H, Li Y and Cui Y: Thymic hyperplasia associated with primary Sjogren's syndrome cured by thymectomy. J Thorac Dis. 9:E130–E132. 2017. View Article : Google Scholar :

3 

Moerman RV, Arends S, Meiners PM, Vissink A, Spijkervet FK, Kroese FG, Brouwer E and Bootsma H: Detailed analysis of the articular domain in patients with primary sjögren syndrome. J Rheumatol. 44:292–296. 2017. View Article : Google Scholar

4 

Zhang N, Yang N, Chen Q, Qiu F and Li X: Upregulated expression level of the growth factor, progranulin, is associated with the development of primary Sjögren's syndrome. Exp Ther Med. 8:1643–1647. 2014. View Article : Google Scholar :

5 

Manganelli P and Fietta P: Apoptosis and Sjögren syndrome. Semin Arthritis Rheum. 33:49–65. 2003. View Article : Google Scholar

6 

Nakamura H, Koji T, Tominaga M, Kawakami A, Migita K, Kawabe Y, Nakamura T, Shirabe S and Eguchi K: Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: Comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients. Clin Exp Immunol. 114:106–112. 1998. View Article : Google Scholar :

7 

Treviño-Talavera BA, Palafox-Sánchez A, Muñoz-Valle JF, Orozco-Barocio G, Navarro-Hernández RE, Vázquez-Del Mercado M, de la Torre García I and Oregon-Romero E: FAS −670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome. Genet Mol Res. 13:4831–4838. 2014. View Article : Google Scholar

8 

Nakamura H: Cell death of salivary gland epithelial cells and involvement of HTLV-I in Sjögren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi. 37:117–124. 2014.(In Japanese). View Article : Google Scholar

9 

Zeng W, Wang X, Xu P, Liu G, Eden HS and Chen X: Molecular imaging of apoptosis: From micro to macro. Theranostics. 5:559–582. 2015. View Article : Google Scholar :

10 

Kong L, Ogawa N, Nakabayashi T, Liu GT, D'Souza E, McGuff HS, Guerrero D, Talal N and Dang H: Fas and fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 40:87–97. 1997. View Article : Google Scholar

11 

Green DR: Apoptotic pathways: Paper wraps stone blunts scissors. Cell. 102:1–4. 2000. View Article : Google Scholar

12 

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al: Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 61:554–558. 2002. View Article : Google Scholar :

13 

Zydowo MM, Swierczyński J, Nagel G and Wrzołkowa T: The respiration and calcium content of heart mitochondria from rats with vitamin D induced carionecrosis. Biochem J. 226:155–161. 1985. View Article : Google Scholar :

14 

Sisto M, Lorusso L and Lisi S: X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome. Clin Exp Med. 17:111–119. 2017. View Article : Google Scholar

15 

Horai Y, Nakamura H, Nakashima Y, Hayashi T and Kawakami A: Analysis of the downstream mediators of toll-like receptor 3-induced apoptosis in labial salivary glands in patients with Sjögren's syndrome. Mod Rheumatol. 26:99–104. 2016. View Article : Google Scholar

16 

Katsiougiannis S, Tenta R and Skopouli FN: Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells. Clin Exp Immunol. 181:244–252. 2015. View Article : Google Scholar :

17 

Zhang Y, Liu H, Jin J, Zhu X, Lu L and Jiang H: The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells. Anticancer Drugs. 21:494–501. 2010. View Article : Google Scholar

18 

Yokogawa Y, Yamauchi R, Saito A, Yamato Y and Toma T: Kinetic modelling of cytochrome c adsorption on SBA-15. Biomed Mater Eng. 28:37–46. 2017.

19 

Song R, Harris LD and Pettaway CA: Downmodulation of Bcl-2 sensitizes metastatic LNCaP-LN3 cells to undergo apoptosis via the intrinsic pathway. Prostate. 70:571–583. 2010.

20 

Lo YT, Huang HW, Huang YC, Chan JF and Hsu YH: Elucidation of tRNA-cytochrome c interactions through hydrogen/deuterium exchange mass spectrometry. Biochim Biophys Acta. 1865:539–546. 2017. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kang Y, Sun Y, Zhang Y and Wang Z: Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome. Mol Med Rep 17: 1993-1997, 2018.
APA
Kang, Y., Sun, Y., Zhang, Y., & Wang, Z. (2018). Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome. Molecular Medicine Reports, 17, 1993-1997. https://doi.org/10.3892/mmr.2017.8083
MLA
Kang, Y., Sun, Y., Zhang, Y., Wang, Z."Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome". Molecular Medicine Reports 17.1 (2018): 1993-1997.
Chicago
Kang, Y., Sun, Y., Zhang, Y., Wang, Z."Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome". Molecular Medicine Reports 17, no. 1 (2018): 1993-1997. https://doi.org/10.3892/mmr.2017.8083
Copy and paste a formatted citation
x
Spandidos Publications style
Kang Y, Sun Y, Zhang Y and Wang Z: Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome. Mol Med Rep 17: 1993-1997, 2018.
APA
Kang, Y., Sun, Y., Zhang, Y., & Wang, Z. (2018). Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome. Molecular Medicine Reports, 17, 1993-1997. https://doi.org/10.3892/mmr.2017.8083
MLA
Kang, Y., Sun, Y., Zhang, Y., Wang, Z."Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome". Molecular Medicine Reports 17.1 (2018): 1993-1997.
Chicago
Kang, Y., Sun, Y., Zhang, Y., Wang, Z."Cytochrome c is important in apoptosis of labial glands in primary Sjogren's syndrome". Molecular Medicine Reports 17, no. 1 (2018): 1993-1997. https://doi.org/10.3892/mmr.2017.8083
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team